Kymera Therapeutics (KYMR) Receivables - Other (2020 - 2025)
Historic Receivables - Other for Kymera Therapeutics (KYMR) over the last 6 years, with Q1 2025 value amounting to $20.0 million.
- Kymera Therapeutics' Receivables - Other rose 90000.0% to $20.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $20.0 million, marking a year-over-year increase of 90000.0%. This contributed to the annual value of $900000.0 for FY2024, which is 7607.66% down from last year.
- Kymera Therapeutics' Receivables - Other amounted to $20.0 million in Q1 2025, which was up 90000.0% from $947000.0 recorded in Q4 2024.
- Kymera Therapeutics' Receivables - Other's 5-year high stood at $20.0 million during Q1 2025, with a 5-year trough of $100000.0 in Q4 2021.
- In the last 5 years, Kymera Therapeutics' Receivables - Other had a median value of $2.0 million in 2024 and averaged $3.1 million.
- Per our database at Business Quant, Kymera Therapeutics' Receivables - Other tumbled by 8831.78% in 2021 and then surged by 240000.0% in 2022.
- Kymera Therapeutics' Receivables - Other (Quarter) stood at $100000.0 in 2021, then surged by 2400.0% to $2.5 million in 2022, then surged by 50.48% to $3.8 million in 2023, then tumbled by 74.83% to $947000.0 in 2024, then surged by 2011.93% to $20.0 million in 2025.
- Its last three reported values are $20.0 million in Q1 2025, $947000.0 for Q4 2024, and $1.3 million during Q3 2024.